Height augmentation in 11β-hydroxylase deficiency congenital adrenal hyperplasia
Conclusions:
This case of a 46,XX patient raised as male with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency highlights a number of unique and difficult treatment challenges; specifically, the role of new therapeutic options for optimization of growth in the context of prior suboptimal disease management.
Source: International Journal of Pediatric Endocrinology - Category: Endocrinology Authors: Munier NourDanièle Pacaud Source Type: research
More News: Anatomy | Congenital Adrenal Hyperplasia | Corticosteroid Therapy | Endocrinology | Hormones | Hypertension | Hysterectomy | Pediatrics